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Introduction
Alzheimer’s Disease (AD) is an extremely debilitating neurodegenerative disease that causes progressive
and substantial memory loss, as well as the loss of other necessary cognitive functions. Despite recent
advances in medicine that have led to the decrease in death from several other diseases, the death toll
for Alzheimer’s continues to rise at an alarming rate. Researches currently consider the pathological
trademark of AD to be the extracellular aggregation of Amyloid-β peptides and intracellular neurofibrillary
tangles in the human brain. The clinical demand for safe and efficient brain imaging capabilities continues
to unfold, and in response, we report the synthesis of various unsymmetrical fluorophores that show
strong potential for being used as tools to successfully diagnose AD. We have taken the current industry
standards for AD diagnostics, Pittsburgh-B and Thioflavin T, and modified them such that they exhibit
near-infrared fluorescence capabilities as opposed to the current methods that require PET imaging and
emit harmful ionizing radiation.
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Method
The primary backbone of these compounds
is a substituted benzothiazole (Figure 1). To
achieve NIR fluorescence capabilities, we
utilized various systems of conjugation
bridging a dimethylamino substituent with
the benzothiazole core using phenyl,
thiophene (data not shown here), and 4methylquinoline (Figure 1). The compounds
were injected into CD-1 mice and imaged
using the FLARE imaging system to
determine their localization and excretion
patterns.
Results

Figure 1: Pittsburgh B and Thioflavin T (top left and right
respectively). Our proposed synthetic design of a NIR compound
modified based on Pittsburgh B and Thioflavin T design (Bottom)

The proposed compounds were successfully synthesized and purified as determined by UV
13
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spectrophotometry, C and H NMR, HPLC and mass spectrometry. As research progresses, additional
compounds with a wide array of substituents will be synthesized based on biological feedback.
Discussion/Conclusion
As the harsh effects of Alzheimer’s continue to take its toll, the need for a method of diagnosis becomes
of the upmost importance. Unsymmetrical fluorophores derived from benzothiazole analogs have been
successfully synthesized and show great promise in initial biological studies. In the future, our
collaborators at Beth Israel Deaconess Medical Center at Harvard Medical School will test their efficacy in
both in vitro and in vivo animal models.
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